Andrea Wang

9.9k total citations · 4 hit papers
65 papers, 7.1k citations indexed

About

Andrea Wang is a scholar working on Orthopedics and Sports Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Andrea Wang has authored 65 papers receiving a total of 7.1k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Orthopedics and Sports Medicine, 21 papers in Oncology and 20 papers in Molecular Biology. Recurrent topics in Andrea Wang's work include Bone health and osteoporosis research (25 papers), Bone health and treatments (21 papers) and Bone Metabolism and Diseases (19 papers). Andrea Wang is often cited by papers focused on Bone health and osteoporosis research (25 papers), Bone health and treatments (21 papers) and Bone Metabolism and Diseases (19 papers). Andrea Wang collaborates with scholars based in United States, Canada and Switzerland. Andrea Wang's co-authors include Ralph Zitnik, Michael R. McClung, Cesar Libanati, Alice B. Gottlieb, Craig L. Leonardi, Steven R. Cummings, Suresh Siddhanti, Ethel S. Siris, Richard Eastell and Matt Austin and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Andrea Wang

62 papers receiving 6.8k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis

2009 2.4k citations Steven R. Cummings, Javier San Martín et al. profile →
Etanercept as Monotherapy in Patients with Psoriasis

2003 935 citations Ralph Zitnik, Andrea Wang et al. profile →
Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial

2005 852 citations Andrea Wang, Ralph Zitnik et al. profile →
10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension

2017 662 citations Henry G. Bone, Rachel B. Wagman et al. The Lancet Diabetes & Endocrinology profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Andrea Wang	3.6k	3.2k	2.4k	1.5k	960	65	7.1k
Paul Van Daele	1.6k 0.4×	890 0.3×	1.1k 0.5×	977 0.7×	902 0.9×	147	5.3k
Lene Heickendorff	1.0k 0.3×	1.2k 0.4×	1.1k 0.4×	416 0.3×	956 1.0×	158	6.7k
Johannes Pfeilschifter	1.5k 0.4×	1.7k 0.5×	2.3k 1.0×	318 0.2×	664 0.7×	102	5.4k
Jens Bollerslev	1.8k 0.5×	2.0k 0.6×	3.3k 1.4×	439 0.3×	2.0k 2.1×	280	10.0k
Jürgen Rech	436 0.1×	417 0.1×	1.3k 0.5×	2.5k 1.7×	786 0.8×	187	7.0k
Yumie Rhee	1.7k 0.5×	1.4k 0.5×	1.7k 0.7×	155 0.1×	931 1.0×	282	5.8k
John G. Hanly	436 0.1×	506 0.2×	617 0.3×	1.9k 1.3×	335 0.3×	137	5.8k
Martin Aringer	165 0.0×	790 0.2×	1.2k 0.5×	3.0k 2.0×	633 0.7×	232	7.5k
Mario Pedrazzoni	899 0.3×	750 0.2×	684 0.3×	498 0.3×	347 0.4×	91	3.3k
Éric Toussirot	326 0.1×	483 0.2×	631 0.3×	1.5k 1.0×	671 0.7×	223	5.2k

Countries citing papers authored by Andrea Wang

Since Specialization

Citations

This map shows the geographic impact of Andrea Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrea Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrea Wang more than expected).

Fields of papers citing papers by Andrea Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrea Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrea Wang. The network helps show where Andrea Wang may publish in the future.

Co-authorship network of co-authors of Andrea Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Andrea Wang. A scholar is included among the top collaborators of Andrea Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrea Wang. Andrea Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Guttman‐Yassky, Emma, Eric L. Simpson, Robert Bissonnette, et al.. (2025). ROCKET: a phase 3 program evaluating the efficacy and safety of rocatinlimab in moderate-to-severe atopic dermatitis. Immunotherapy. 17(2). 83–94. 5 indexed citations

Wang, Andrea, Menaka Pai, Yang Liu, et al.. (2023). Impact of iron supplementation on patient outcomes for women with abnormal uterine bleeding: a protocol for a systematic review and meta-analysis. Systematic Reviews. 12(1). 121–121. 2 indexed citations

Wang, Andrea, et al.. (2023). How accurate is the human olfactory system in detecting peanuts?. International Forum of Allergy & Rhinology. 14(4). 873–875. 1 indexed citations

Tepper, Stewart J., Richard B. Lipton, Stephen D. Silberstein, et al.. (2023). Long‐term efficacy and safety of erenumab in patients with chronic migraine and acute medication overuse: A subgroup analysis. Headache The Journal of Head and Face Pain. 63(6). 730–742. 5 indexed citations

Hwang, Stephen W., et al.. (2023). “When I think about my future, I just see darkness”: How youth exiting homelessness navigate the hazy, liminal space between socioeconomic exclusion and inclusion. Canadian Journal of Public Health. 114(6). 893–905. 3 indexed citations

Wang, Andrea, et al.. (2021). Tackling exclusion: A pilot mixed method quasi-experimental identity capital intervention for young people exiting homelessness. PLoS ONE. 16(8). e0256288–e0256288. 8 indexed citations

Mikol, Daniel D., et al.. (2020). Migraine Polygenic Risk Score Is Associated with Severity of Migraine – Analysis of Genotypic Data from Four Placebo-controlled Trials of Erenumab (1214). Neurology. 94(15_supplement). 1 indexed citations

Kozloff, Nicole, et al.. (2019). Evaluating the Effects of a Rent Subsidy and Mentoring Intervention for Youth Transitioning Out of Homelessness: Protocol for a Mixed Methods, Community-Based Pilot Randomized Controlled Trial. SHILAP Revista de lepidopterología. 8(12). e15557–e15557. 4 indexed citations

Saag, Kenneth G., Rachel B. Wagman, Piet Geusens, et al.. (2018). Denosumab versus risedronate in glucocorticoid-induced osteoporosis: a multicentre, randomised, double-blind, active-controlled, double-dummy, non-inferiority study. The Lancet Diabetes & Endocrinology. 6(6). 445–454. 136 indexed citations

10.

Adachi, Jonathan D., Henry G. Bone, Nadia Daizadeh, et al.. (2017). Influence of subject discontinuation on long-term nonvertebral fracture rate in the denosumab FREEDOM Extension study. BMC Musculoskeletal Disorders. 18(1). 174–174. 11 indexed citations

11.

Schmiedt, Chad W., et al.. (2013). Adrenal gland function in a dog following unilateral complete adrenalectomy and contralateral partial adrenalectomy. Journal of the American Veterinary Medical Association. 242(10). 1398–1404. 1 indexed citations

12.

Brown, Jacques P., Christian Roux, Ove Törring, et al.. (2012). Discontinuation of denosumab and associated fracture incidence: Analysis from the Fracture Reduction Evaluation of Denosumab in Osteoporosis Every 6 Months (FREEDOM) Trial. Journal of Bone and Mineral Research. 28(4). 746–752. 108 indexed citations

13.

Simon, James A., Christopher Recknor, Alfred H. Moffett, et al.. (2012). Impact of denosumab on the peripheral skeleton of postmenopausal women with osteoporosis. Menopause The Journal of The North American Menopause Society. 20(2). 130–137. 32 indexed citations

14.

McClung, Michael R., José Zanchetta, Arne Høiseth, et al.. (2012). Denosumab Densitometric Changes Assessed by Quantitative Computed Tomography at the Spine and Hip in Postmenopausal Women With Osteoporosis. Journal of Clinical Densitometry. 16(2). 250–256. 26 indexed citations

15.

Eastell, Richard, Claus Christiansen, Andreas Grauer, et al.. (2010). Effects of denosumab on bone turnover markers in postmenopausal osteoporosis. Journal of Bone and Mineral Research. 26(3). 530–537. 178 indexed citations

16.

Cummings, Steven R., Javier San Martín, Michael R. McClung, et al.. (2009). Denosumab for Prevention of Fractures in Postmenopausal Women With Osteoporosis. Obstetrical & Gynecological Survey. 64(12). 805–807. 41 indexed citations

17.

Davidson, Bruce J., Elizabeth Guardiani, & Andrea Wang. (2009). Adopting the operating microscope in thyroid surgery: Safety, efficiency, and ergonomics. Head & Neck. 32(2). 154–159. 26 indexed citations

18.

Guess, Marsha K., Kathleen A. Connell, Steven M. Schrader, et al.. (2006). Genital Sensation and Sexual Function in Women Bicyclists and Runners: Are Your Feet Safer Than Your Seat?. The Journal of Sexual Medicine. 3(6). 1018–1027. 35 indexed citations

19.

Nestorov, Ivan, Ralph Zitnik, Todd DeVries, et al.. (2006). Pharmacokinetics of subcutaneously administered etanercept in subjects with psoriasis. British Journal of Clinical Pharmacology. 62(4). 435–445. 40 indexed citations

20.

Wang, Andrea. (2001). Illinois v. Wardlow and the Crisis of Legitimacy: An Argument for a Real Cost Balancing Test. Minnesota journal of law & inequality. 19(1). 1. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact